Zinhle Matsebula

TL;DR: There are multiple activities across Africa to reduce the spread of COVID-19 and address misinformation, which can have catastrophic consequences, assisted by the WHO and others, which appear to be working in a number of countries.

TL;DR: There is a need to document current practices and successful initiatives in LMICs to improve future antimicrobial use, and initiatives to reduce inappropriate prescribing and dispensing of antimicrobials for URTIs as part of NAPs and other activities, are monitored.

TL;DR: The primary aim of this paper is to consider potential ways to optimize the use of new medicines balancing rising costs with increasing budgetary pressures to stimulate debate especially from a payer perspective.

TL;DR: There are a number of ongoing activities across Africa to improve the management of patients with diabetes including co-morbidities, however, more needs to be done considering the high and growing burden of T2DM in Africa.

TL;DR: There are concerns with the management of patients with T1DM across Africa, and there are ongoing developments to address the multiple challenges including the instigation of universal health care and partnerships with non-governmental organizations, patient organizations, and pharmaceutical companies.